Skip to main content
OpenTrials

Clinical trial condition

Refractory Hormone Receptor Positive Breast Carcinoma

Explore clinical trials studying Refractory Hormone Receptor Positive Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory Hormone Receptor Positive Breast Carcinoma trial results

Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details

Related conditions